Evaluating the clinical effectiveness and safety of various HER2-targeted regimens after prior taxane/trastuzumab in patients with previously treated, unresectable, or metastatic HER2-positive breast cancer: a systematic review and network meta-analysis

  1. Paracha, N.
  2. Reyes, A.
  3. Diéras, V.
  4. Krop, I.
  5. Pivot, X.
  6. Urruticoechea, A.
Aldizkaria:
Breast Cancer Research and Treatment

ISSN: 1573-7217 0167-6806

Argitalpen urtea: 2020

Alea: 180

Zenbakia: 3

Orrialdeak: 597-609

Mota: Berrikuspena

DOI: 10.1007/S10549-020-05577-7 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak